Health approves ‘Jardiance’ (Boehringer Ingelheim and Lilly) for patients with chronic kidney disease

#Health #approves #Jardiance #Boehringer #Ingelheim #Lilly #patients #chronic #kidney #disease The Alianza Boehringer Ingelheim y Lilly announced this Wednesday that the Ministry of Health has approved the financing of ‘Jardiance’ (empagliflozin) for the treatment of adults with chronic kidney disease (CKD), which has been shown to reduce the risk of progression of kidney disease or […]
The post Health approves ‘Jardiance’ (Boehringer Ingelheim and Lilly) for patients with chronic kidney disease appeared first on World Today Journal.